Dan Ferry | IR, LifeSci Advisors |
Avanish Vellanki | CEO |
Nelson Cabatuan | Acting SVP, Finance |
Robert Doebele | CSO |
Ashiq Mubarack | Citigroup |
Joe Catanzaro | Piper Sandler |
Anshul Dhankher | LifeSci Capital |
Avantika Joshi | Mizuho Securities |
Mitchell Kapoor | H.C. Wainwright |
Good afternoon, ladies and gentlemen, and welcome to the Rain Oncology Inc.
Second Quarter 2023 Earnings Conference Call. At this time, all lines are in listen-only mode and following the presentation we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Thursday, August 10, 2023.
I would now like to turn the conference call over to Mr.